Search

everythinglearnresearchcommunity

for

Search:↓

Tofacitinib effectively treated a woman's complex autoimmune and autoinflammatory disorders.

Finasteride increases P-glycoprotein activity in the liver and kidney.

Finasteride and GIZh-72 reduce inflammation, with GIZh-72 being more effective.

BMS-470539 reduces skin fibrosis and inflammation.

Tofacitinib might be used to treat hair loss.

DPP4-positive fibroblasts play a major role in producing proteins that lead to skin fibrosis.

The guidelines help doctors manage skin problems from certain cancer treatments to improve patients' lives.

Shortened PEDF peptides speed up skin wound healing by boosting cell growth.

Apigenin may help promote hair growth and could treat hair loss.

The new compound was more effective than finasteride in reducing markers of hair loss and prostate issues in cell tests.

Tideglusib with a bacterial cellulose hydrogel improves wound healing in rats.

Combining MMP-9 and JAK inhibitors can effectively prevent skin depigmentation in vitiligo.

Ritlecitinib is the first FDA-approved pill for treating significant hair loss in alopecia areata patients aged 12 and up.

A new peptide, murikal/SPR4, was found to significantly increase hair growth in mice, and its liposomal topical formulations enhanced hair growth more than commercial products. However, results on human scalp skin were unclear, needing more tests.

Glibenclamide slows breast cancer cell growth by stopping cell division.

Oral tofacitinib successfully treated a girl's severe skin and hair conditions.

Continued ritlecitinib treatment can lead to hair regrowth in some patients with alopecia areata who initially don't respond.

MK-2206 was safe and effectively blocked AKT signaling in cancer patients, warranting more trials.

Ritlecitinib was generally well tolerated in children with alopecia areata.

The compound GD-23 may reduce anxiety like diazepam by targeting the TSPO receptor.

The treatment increased total hair count but wasn't significantly better than placebo.

Tofacitinib works well for treating alopecia areata, especially when combined with corticosteroids, but is less effective if the disease has lasted over 2 years.

FOL-005 peptide may help treat excessive hair growth safely.

Upadacitinib effectively treats severe alopecia areata and is safe.

Plumbagin may help protect cells, reduce inflammation, and has potential for treating various diseases, but more research is needed.

Nirogacestat can cause severe skin issues like hidradenitis suppurativa.

A new compound with strong antiandrogenic effects was found, potentially useful for treating conditions like acne and prostate cancer.